DCF — UPPER CHESAPEAKE MEDICAL CENTER
Enterprise Value: $21.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$21.1M
Enterprise Value
$-2.1M
PV of Cash Flows
$23.2M
PV of Terminal Value
$37.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $329.8M | $10.0M | 3.0% | $-4.4M | $-4.0M |
| Year 2 | $339.7M | $13.7M | 4.0% | $-2.0M | $-1.6M |
| Year 3 | $349.9M | $17.6M | 5.0% | $0.6M | $0.5M |
| Year 4 | $360.4M | $20.0M | 6.0% | $2.0M | $1.3M |
| Year 5 | $371.2M | $21.5M | 6.0% | $2.7M | $1.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $21.1M. Terminal value accounts for 110% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$320.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.025412314699259544
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5